{
  "id": 21881,
  "name": "Kernal Biologics",
  "slug": "kernal-biologics",
  "former_names": [],
  "small_logo_thumb_url": "https://bookface-images.s3.amazonaws.com/small_logos/1534fd5c3c1e4705596c793a4a59a28da388bacf.png",
  "website": "https://www.kernalbio.com/",
  "all_locations": "Cambridge, MA, USA",
  "long_description": "Kernal Bio is a biotech company pioneering mRNA 2.0 immunotherapies. We leverage selective mRNA-LNP technology to treat cancer and autoimmune diseases with precision, ensuring targeted cell delivery and minimal off-target effects. Our KR-402 program achieves over 90% delivery efficiency with T-cell-targeted LNPs, enabling direct CAR-T programming within the body and resulting in B-cell depletion within a week.\r\n \r\nKernal Bio is led by a team with experience from MIT, Harvard, Merck, and BMS, boasting three FDA-approved therapies and over 120 patents. Based in Cambridge, MA, we are backed by Hummingbird Ventures, Amgen Ventures, HBM, and even NASA.\r\n\r\nWith roots at MIT, Harvard and Biopharma, Kernalâ€™s management team has deep expertise in mRNA therapeutics space. CEO Yusuf Erkul, M.D., M.B.A. is a successful drug hunter whose research at Merck enabled an FDA-approved drug for ovarian cancer. President Burak Yilmaz, M.S., previously founded Sentegen, a thriving synthetic biology company which commercializes synthetic DNA, RNA, and diagnostic kits for genetic and infectious diseases. Sr. VP of R&D Manfred Kraus is a leader in immuno-oncology, who was most recently Scientific Sr. Director at Bristol-Myers Squibb (BMS). ",
  "one_liner": "Kernal is creating mRNA 2.0 therapies that work in specific cells",
  "team_size": 20,
  "industry": "Healthcare",
  "subindustry": "Healthcare -> Therapeutics",
  "launched_at": 1599762607,
  "tags": [
    "Artificial Intelligence",
    "Biotech",
    "Genomics"
  ],
  "tags_highlighted": [],
  "top_company": false,
  "isHiring": false,
  "nonprofit": false,
  "batch": "Summer 2020",
  "status": "Active",
  "industries": [
    "Healthcare",
    "Therapeutics"
  ],
  "regions": [
    "United States of America",
    "America / Canada"
  ],
  "stage": "Early",
  "app_video_public": false,
  "demo_day_video_public": false,
  "app_answers": null,
  "question_answers": false,
  "url": "https://www.ycombinator.com/companies/kernal-biologics",
  "api": "https://yc-oss.github.io/api/batches/summer-2020/kernal-biologics.json"
}
